 Halden Scott
Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sepsis | 32 | 2024 | 509 | 9.700 |
Why?
| | Shock, Septic | 15 | 2024 | 186 | 3.490 |
Why?
| | Emergency Service, Hospital | 18 | 2023 | 1820 | 2.510 |
Why?
| | Hospital Mortality | 11 | 2024 | 776 | 1.800 |
Why?
| | Multiple Organ Failure | 8 | 2024 | 146 | 1.790 |
Why?
| | Lactic Acid | 4 | 2020 | 275 | 1.490 |
Why?
| | Hospitals, Pediatric | 7 | 2023 | 480 | 1.410 |
Why?
| | Systemic Inflammatory Response Syndrome | 4 | 2024 | 72 | 1.370 |
Why?
| | Organ Dysfunction Scores | 9 | 2024 | 39 | 1.300 |
Why?
| | Child | 41 | 2024 | 18422 | 1.140 |
Why?
| | Critical Care | 9 | 2021 | 476 | 1.000 |
Why?
| | Intensive Care Units, Pediatric | 3 | 2020 | 148 | 0.810 |
Why?
| | Guideline Adherence | 3 | 2021 | 490 | 0.720 |
Why?
| | Hyperlactatemia | 1 | 2019 | 3 | 0.670 |
Why?
| | Quality of Health Care | 2 | 2023 | 573 | 0.670 |
Why?
| | Thiamine Deficiency | 1 | 2019 | 8 | 0.670 |
Why?
| | Quality Improvement | 4 | 2021 | 950 | 0.650 |
Why?
| | Hospitals | 2 | 2021 | 581 | 0.620 |
Why?
| | Motivation | 1 | 2022 | 494 | 0.600 |
Why?
| | Patient Admission | 1 | 2019 | 176 | 0.600 |
Why?
| | Community Health Centers | 1 | 2018 | 54 | 0.580 |
Why?
| | Child, Preschool | 17 | 2022 | 9119 | 0.580 |
Why?
| | Tertiary Care Centers | 1 | 2018 | 126 | 0.560 |
Why?
| | Electronic Health Records | 2 | 2020 | 800 | 0.550 |
Why?
| | Diagnostic Errors | 1 | 2018 | 149 | 0.550 |
Why?
| | Physical Examination | 2 | 2015 | 222 | 0.540 |
Why?
| | Infant | 15 | 2022 | 7964 | 0.520 |
Why?
| | Humans | 46 | 2024 | 114709 | 0.520 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 213 | 0.520 |
Why?
| | Severity of Illness Index | 3 | 2020 | 2540 | 0.510 |
Why?
| | Retrospective Studies | 15 | 2024 | 12556 | 0.510 |
Why?
| | Intubation, Intratracheal | 1 | 2018 | 216 | 0.510 |
Why?
| | Risk Assessment | 3 | 2020 | 2968 | 0.510 |
Why?
| | Sensitivity and Specificity | 6 | 2018 | 1694 | 0.490 |
Why?
| | Pediatrics | 5 | 2020 | 981 | 0.470 |
Why?
| | Meningitis | 1 | 2015 | 74 | 0.470 |
Why?
| | Fluid Therapy | 4 | 2020 | 123 | 0.470 |
Why?
| | Adolescent | 17 | 2022 | 17855 | 0.420 |
Why?
| | Lactates | 1 | 2012 | 79 | 0.410 |
Why?
| | Algorithms | 1 | 2019 | 1470 | 0.410 |
Why?
| | Critical Illness | 4 | 2021 | 646 | 0.400 |
Why?
| | Length of Stay | 4 | 2021 | 962 | 0.400 |
Why?
| | Hospitalization | 3 | 2021 | 1752 | 0.400 |
Why?
| | Anti-Bacterial Agents | 6 | 2022 | 1481 | 0.400 |
Why?
| | Intensive Care Units | 2 | 2021 | 617 | 0.390 |
Why?
| | Albumins | 1 | 2011 | 89 | 0.370 |
Why?
| | Sodium Chloride | 1 | 2011 | 136 | 0.360 |
Why?
| | Shock | 1 | 2011 | 84 | 0.350 |
Why?
| | Male | 18 | 2022 | 55609 | 0.300 |
Why?
| | Guidelines as Topic | 2 | 2020 | 243 | 0.300 |
Why?
| | Prognosis | 4 | 2022 | 3330 | 0.280 |
Why?
| | Cohort Studies | 5 | 2020 | 4895 | 0.280 |
Why?
| | Female | 18 | 2022 | 59523 | 0.270 |
Why?
| | Vasoconstrictor Agents | 4 | 2020 | 113 | 0.260 |
Why?
| | Emergency Treatment | 2 | 2022 | 113 | 0.220 |
Why?
| | Respiration, Artificial | 4 | 2022 | 529 | 0.210 |
Why?
| | Early Diagnosis | 2 | 2014 | 217 | 0.200 |
Why?
| | Practice Guidelines as Topic | 3 | 2020 | 1395 | 0.200 |
Why?
| | Registries | 3 | 2020 | 1768 | 0.190 |
Why?
| | Infant, Newborn | 6 | 2022 | 5047 | 0.190 |
Why?
| | Resuscitation | 3 | 2020 | 252 | 0.190 |
Why?
| | Education, Continuing | 1 | 2020 | 39 | 0.180 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2020 | 30 | 0.170 |
Why?
| | Positive-Pressure Respiration | 1 | 2020 | 68 | 0.170 |
Why?
| | Thiamine | 1 | 2019 | 11 | 0.170 |
Why?
| | Consensus | 4 | 2024 | 539 | 0.160 |
Why?
| | Immunocompromised Host | 1 | 2020 | 195 | 0.160 |
Why?
| | New York | 1 | 2018 | 106 | 0.160 |
Why?
| | Patient Care Bundles | 1 | 2017 | 17 | 0.140 |
Why?
| | Drug Utilization Review | 1 | 2017 | 57 | 0.140 |
Why?
| | Veins | 1 | 2017 | 55 | 0.140 |
Why?
| | Musculoskeletal Diseases | 1 | 2017 | 54 | 0.140 |
Why?
| | Heart Rate | 2 | 2021 | 709 | 0.130 |
Why?
| | Arteries | 1 | 2017 | 247 | 0.120 |
Why?
| | Prospective Studies | 3 | 2021 | 6220 | 0.120 |
Why?
| | Incidence | 2 | 2019 | 2313 | 0.120 |
Why?
| | Acute Kidney Injury | 1 | 2021 | 638 | 0.120 |
Why?
| | Patient Discharge | 1 | 2021 | 773 | 0.120 |
Why?
| | Mass Screening | 1 | 2021 | 1006 | 0.120 |
Why?
| | Abscess | 2 | 2017 | 72 | 0.120 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1121 | 0.120 |
Why?
| | Hypotension | 1 | 2015 | 116 | 0.120 |
Why?
| | Body Temperature | 1 | 2015 | 208 | 0.110 |
Why?
| | Hemodynamics | 4 | 2020 | 1012 | 0.110 |
Why?
| | Prevalence | 3 | 2015 | 2251 | 0.110 |
Why?
| | Reproducibility of Results | 1 | 2020 | 2765 | 0.110 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2015 | 223 | 0.100 |
Why?
| | Likelihood Functions | 1 | 2012 | 126 | 0.100 |
Why?
| | Heart Arrest | 1 | 2015 | 293 | 0.100 |
Why?
| | Confidence Intervals | 1 | 2012 | 305 | 0.100 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 2 | 2011 | 191 | 0.090 |
Why?
| | Staphylococcal Skin Infections | 1 | 2011 | 29 | 0.090 |
Why?
| | Emergency Medical Services | 2 | 2015 | 590 | 0.090 |
Why?
| | Cause of Death | 1 | 2012 | 361 | 0.090 |
Why?
| | Proteus mirabilis | 1 | 2010 | 3 | 0.090 |
Why?
| | Proteus Infections | 1 | 2010 | 4 | 0.090 |
Why?
| | Skin Diseases, Infectious | 1 | 2010 | 15 | 0.090 |
Why?
| | Colorado | 1 | 2019 | 4100 | 0.090 |
Why?
| | Skin Diseases, Bacterial | 1 | 2010 | 22 | 0.090 |
Why?
| | ROC Curve | 2 | 2022 | 442 | 0.080 |
Why?
| | Logistic Models | 1 | 2014 | 1841 | 0.080 |
Why?
| | Soft Tissue Infections | 1 | 2010 | 30 | 0.080 |
Why?
| | Biomarkers | 2 | 2017 | 3408 | 0.080 |
Why?
| | Time Factors | 2 | 2017 | 6116 | 0.080 |
Why?
| | Sex Factors | 1 | 2012 | 1715 | 0.070 |
Why?
| | Risk Factors | 2 | 2018 | 8634 | 0.070 |
Why?
| | Age Factors | 1 | 2012 | 2894 | 0.060 |
Why?
| | Cardiovascular Agents | 2 | 2017 | 126 | 0.060 |
Why?
| | Monitoring, Physiologic | 2 | 2017 | 249 | 0.060 |
Why?
| | United States | 5 | 2020 | 12186 | 0.060 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2017 | 241 | 0.050 |
Why?
| | Consciousness | 1 | 2022 | 20 | 0.050 |
Why?
| | Patient Acuity | 1 | 2022 | 42 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 1 | 2010 | 1177 | 0.050 |
Why?
| | Clinical Laboratory Techniques | 1 | 2022 | 87 | 0.050 |
Why?
| | Global Health | 1 | 2022 | 287 | 0.040 |
Why?
| | Complement Activation | 1 | 2021 | 340 | 0.040 |
Why?
| | Pyomyositis | 1 | 2017 | 13 | 0.040 |
Why?
| | Anti-Infective Agents | 1 | 2020 | 225 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2020 | 1075 | 0.040 |
Why?
| | Central Venous Catheters | 1 | 2017 | 40 | 0.040 |
Why?
| | Arthritis, Infectious | 1 | 2017 | 49 | 0.030 |
Why?
| | Medical Records | 1 | 2017 | 153 | 0.030 |
Why?
| | Drug Utilization | 1 | 2017 | 167 | 0.030 |
Why?
| | Fever | 1 | 2017 | 280 | 0.030 |
Why?
| | Osteomyelitis | 1 | 2017 | 105 | 0.030 |
Why?
| | Atropine | 1 | 2015 | 25 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2020 | 668 | 0.030 |
Why?
| | Isotonic Solutions | 1 | 2015 | 39 | 0.030 |
Why?
| | Anesthesia | 1 | 2017 | 117 | 0.030 |
Why?
| | Ventricular Fibrillation | 1 | 2015 | 51 | 0.030 |
Why?
| | Emergency Responders | 1 | 2015 | 33 | 0.030 |
Why?
| | Early Medical Intervention | 1 | 2015 | 52 | 0.030 |
Why?
| | Electric Countershock | 1 | 2015 | 104 | 0.030 |
Why?
| | International Classification of Diseases | 1 | 2015 | 116 | 0.030 |
Why?
| | Acute Disease | 1 | 2017 | 911 | 0.030 |
Why?
| | Research Design | 1 | 2020 | 928 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 2015 | 218 | 0.030 |
Why?
| | Patient Readmission | 1 | 2017 | 610 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 1796 | 0.020 |
Why?
| | Clindamycin | 1 | 2010 | 12 | 0.020 |
Why?
| | Axilla | 1 | 2010 | 39 | 0.020 |
Why?
| | Cellulitis | 1 | 2010 | 45 | 0.020 |
Why?
| | Treatment Failure | 1 | 2011 | 331 | 0.020 |
Why?
| | Community-Acquired Infections | 1 | 2010 | 141 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2010 | 539 | 0.020 |
Why?
| | Adult | 2 | 2022 | 30554 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2017 | 9088 | 0.010 |
Why?
| | Young Adult | 1 | 2015 | 10472 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2010 | 4410 | 0.010 |
Why?
|
|
Scott's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|